Sen. Wyden Makes Final Request to Amgen for Voluntary Compliance in Pharma Tax Investigation
December 09, 2022
December 09, 2022
WASHINGTON, Dec. 9 -- Sen. Ron Wyden, D-Oregon, chairman of the Senate Finance Committee, issued the following news release on Dec. 8, 2022, and letter:
Senate Finance Committee Chair Ron Wyden, D-Ore., today continued his investigation of Big Pharma's tax practices with a final request to Amgen for voluntary compliance in providing information about efforts to avoid billions in taxes through profit-shifting to subsidiaries in Puerto Rico.
Wyden's letter follows a previ . . .
Senate Finance Committee Chair Ron Wyden, D-Ore., today continued his investigation of Big Pharma's tax practices with a final request to Amgen for voluntary compliance in providing information about efforts to avoid billions in taxes through profit-shifting to subsidiaries in Puerto Rico.
Wyden's letter follows a previ . . .